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Addition of 24-Hour Heart Rate Variability Parameters to the
Cardiovascular Health Study Stroke Risk Score and Prediction of
Incident Stroke: The Cardiovascular Health Study
Rohan K. Bodapati, MD; Jorge R. Kizer, MD, MSc; Willem J. Kop, PhD; Hooman Kamel, MD; Phyllis K. Stein, PhD, SEP
Background-—Heart rate variability (HRV) characterizes cardiac autonomic functioning. The association of HRV with stroke is
uncertain. We examined whether 24-hour HRV added predictive value to the Cardiovascular Health Study clinical stroke risk score
(CHS-SCORE), previously developed at the baseline examination.
Methods and Results-—N=884 stroke-free CHS participants (age 75.34.6), with 24-hour Holters adequate for HRV analysis at
the 1994–1995 examination, had 68 strokes over ≤8 year follow-up (median 7.3 [interquartile range 7.1–7.6] years). The value of
adding HRV to the CHS-SCORE was assessed with stepwise Cox regression analysis. The CHS-SCORE predicted incident stroke
(HR=1.06 per unit increment, P=0.005). Two HRV parameters, decreased coefﬁcient of variance of NN intervals (CV%, P=0.031)
and decreased power law slope (SLOPE, P=0.033) also entered the model, but these did not signiﬁcantly improve the c-statistic
(P=0.47). In a secondary analysis, dichotomization of CV% (LOWCV% ≤12.8%) was found to maximally stratify higher-risk
participants after adjustment for CHS-SCORE. Similarly, dichotomizing SLOPE (LOWSLOPE <1.4) maximally stratiﬁed higher-risk
participants. When these HRV categories were combined (eg, HIGHCV% with HIGHSLOPE), the c-statistic for the model with the
CHS-SCORE and combined HRV categories was 0.68, signiﬁcantly higher than 0.61 for the CHS-SCORE alone (P=0.02).
Conclusions-—In this sample of older adults, 2 HRV parameters, CV% and power law slope, emerged as signiﬁcantly associated
with incident stroke when added to a validated clinical risk score. After each parameter was dichotomized based on its optimal cut
point in this sample, their composite signiﬁcantly improved prediction of incident stroke during ≤8-year follow-up. These ﬁndings
will require validation in separate, larger cohorts. ( J Am Heart Assoc. 2017;6:e004305. DOI: 10.1161/JAHA.116.004305.)
Key Words: autonomic nervous system • clinical stroke risk model • heart rate variability • prediction • predictors • risk
prediction • risk stratiﬁcation • stroke
T he addition of heart rate variability (HRV) to clinical riskfactors has been shown to improve prediction of
cardiovascular outcomes in the CHS (Cardiovascular Health
Study).1 HRV measures have also been used to gauge the
effect of stroke on autonomic control of cardiac activity, and
to improve prediction of poststroke outcomes.2–11 However,
the relationship of HRV with incident stroke is less clear.12,13
We therefore examined whether 24-hour-Holter-based HRV
measures and/or ectopy counts would improve the predictive
value of the previously validated Cardiovascular Health Study
stroke risk score (CHS-SCORE), when applied to a subset of
the CHS with available 24-hour Holter recordings.14
Methods
Study Population
Recruitment methods for the CHS have been published.15 In
brief, a random sample of individuals ≥65 years of age,
derived from government-sponsored health insurance (Medi-
care) eligibility lists in 4 communities, as well as other
biologically unrelated household members who were
≥65 years of age, were invited to participate in the study.
Potential participants were excluded if they were
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institutionalized, unable to attend clinic visits, or had illnesses
that were expected to lead to early death. N=5201 partici-
pants were recruited in 1989–1990 (original cohort). Another
687 individuals were recruited in 1992–1993 to provide
additional representation of blacks (supplemental cohort). All
participants signed informed consent upon entry into the
study. At the time of the 1994–1995 follow-up examination,
1196 participants underwent 24-hour Holter monitoring. After
excluding participants who had 24-hour Holter recordings
with atrial ﬁbrillation (AF), paced rhythm, wandering atrial
pacemaker or inadequate signal quality for full HRV analysis
(N=120), with prevalent stroke at the 1994–1995 visit
(N=72), or with missing values for covariates forming part
of the CHS stroke risk model (N=9), there were 884
participants eligible for complete HRV analysis. This study
conforms to the Declaration of Helsinki and was approved by
the local Human Research Protection Organization.
Calculation of Stroke Risk Scores
A CHS-SCORE was calculated for all of the participants in the
1994–1995 Holter subcohort using the CHS stroke risk model
previously developed in the original and supplemental cohorts
at their baseline CHS examinations (1989–1990 and 1992–
1993, respectively).14 The CHS stroke risk model is shown in
Table 1.14 We used clinical covariates obtained at the time of
the Holter recording for calculation of the CHS-SCORE at the
1994–1995 examination. For serum glucose and creatinine,
we carried forward measures from the 1992–1993
examination, because fasting values were not available at
the 1994–1995 visit.
Ambulatory ECG Monitoring and Assessment of
HRV
Holter tapes were recorded on Del Mar Avionics devices,
which have a calibrated timing signal. Data were processed by
research technicians at the Washington University School of
Medicine Heart Rate Variability Laboratory (St Louis, MO),
using a GE Marquette MARS 8000 Holter Analyzer (GE-
Marquette, Milwaukee, WI). All Holter analyses were reviewed
in detail by 1 investigator (P.K.S.), with special attention paid
to ensuring that only normal beats with uniformly detected
onsets were labeled as normal. The longest and shortest true





71 to 77 3 5
78 to 84 6 10
85 to 91 9 15
≥92 12 20
History of heart disease 5 1
Atrial fibrillation by ECG 16 5
Systolic blood pressure (mm Hg)
<120 0
120 to 129 1
130 to 139 3
140 to 149 5
150 to 159 7
160 to 169 9
170 to 179 11
>180 13
15-foot walk time 1 per s (maximum 20)
Left ventricular hypertrophy by ECG 6
Creatinine >1.25 mg/dL 2
Impaired fasting glucose (American
Diabetes Association)
4
Diabetes mellitus (American Diabetes
Association)
6
The stroke risk at 5 years ranges from 2.5% in men and 3.5% in women with a total risk
score of 1 to 5, to as high as 59% in men and 39% in women for a total risk score of 41 to
45.14 CHS indicates Cardiovascular Health Study.
Clinical Perspective
What Is New?
• Multiple heart rate variability (HRV) measures derived from
24-hour Holter recordings were used to explore the
association between HRV and incident stroke.
• The incremental value of HRV measures to a validated
clinical risk score for prediction of incident stroke was
assessed for the ﬁrst time.
• HRV measures identiﬁed an underlying autonomic dysfunc-
tion in older individuals with apparently normal sinus rhythm
that was associated with onset of stroke years later.
What Are the Clinical Implications?
• HRV parameters were independently associated with inci-
dent stroke, and could potentially improve stroke risk
prediction, a possibility that will require further testing in
separate populations.
• Early detection of underlying autonomic dysfunction using
readily calculated data from an ambulatory Holter recording
could prove helpful for planning interventions to prevent
incidence of cerebrovascular events.
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normal-to-normal (N-N) intervals were identiﬁed for each tape,
and intervals outside of these limits, including blocked atrial
premature contractions, were excluded from all HRV calcula-
tions. Participants with a paced rhythm, AF, or wandering
atrial pacemaker were excluded from the analysis. Our prior
analysis has shown that the demographic and clinical factors
in those who volunteered for Holter recordings and the total
CHS cohort were similar.16
Time domain, frequency domain, and nonlinear HRV and
ectopy counts were calculated from annotated beat-to-beat
ﬁles exported to a Sun Enterprise 450 server (Sun
Microsystems, Santa Clara, CA) using validated research
software. We included only participants with complete data
(ie, those whose recordings fulﬁlled prespeciﬁed data
quality criteria for all HRV analyses). These criteria
comprised normal sinus rhythm with ≥18 hours of 5-minute
segments, each of which had ≥80% N-N intervals present in
each segment and <20% ectopic beats. These criteria are
based on the fact that some frequency domain HRV
measures are calculated per 5 minutes and averaged. For
each non-normal beat, whether because of artifact or
ectopy, the interval between the normal beat before it, as
well as the interval after the non-normal beat and the next
normal beat, cannot be an N-N interval and is replaced by
an average to avoid adding spurious HRV. Therefore, when
20% or more of beats are removed from a 5-minute
segment, the result is that only 40% or less of N-N intervals
are available for the calculation of HRV and that interval is
excluded.
An overview of the different types of HRV measures and
the information they provide is given below:
Time domain HRV provides statistical estimates of “how
much” HRV there is at various time scales.17 For example,
the well-known HRV measure, standard deviation of
normal-to-normal-beats (SDNN), is the SD of the intervals
between all of the N-N intervals (measured in milliseconds)
over the entire 24-hour recording.
Frequency domain HRV parameters express the magnitude
of the variance in the N-N time series associated with
speciﬁc bands of underlying rhythms using a fast Fourier
transform.17 For example, high-frequency power captures
how much of the variance in the N-N interval time series is
explained by oscillations at frequencies consistent with
respiration (in adults 9–24 cycles/min) and reﬂects respi-
ratory sinus arrhythmia.
Less well-known are the nonlinear HRV measures which,
broadly speaking, capture the degree of “organization” of the
N-N interval time series and may capture prognostic infor-
mation beyond that of time and frequency domain HRV.18 At 1
extreme, the heart rate pattern could be completely, math-
ematically random, and at the other extreme, it could be
completely predictable, consisting of a single underlying
oscillatory pattern. Healthy HRV falls somewhere in between
these extremes. Thus, a very irregular N-N interval time series,
such as that seen in AF, would have high values for time
domain HRV, would have an abnormal distribution of under-
lying oscillatory frequencies in the frequency domain, and
would be clearly abnormally organized in the nonlinear
domain.
Outcome
Incident stroke after the 1994–1995 examination was the
primary outcome. Therefore, time to stroke, as recorded in
the CHS database, was adjusted to capture the time to
strokes occurring after the Holter recording visit. Follow-up
for incident stroke extended through 2002. At the end of
follow-up, among participants with eligible Holter record-
ings, there were 68 strokes of which 55 were classiﬁed as
ischemic, 8 as hemorrhagic, and 5 as unknown. Ascertain-
ment and adjudication of stroke has been previously
reported.19 Brieﬂy, potential stroke events were identiﬁed
during annual follow-up examinations and at interim 6-
month phone contacts. The participant, or his or her next
of kin, was interviewed shortly after the event about the
surrounding circumstances. Hospital records for all reported
strokes, as well as nonstroke hospitalizations with Interna-
tional Classiﬁcation of Diseases, 9th Revision, codes 430
through 438 identifying cerebrovascular disease, were
abstracted for pertinent information and reviewed by a
neurologist at each ﬁeld center. Information on reported
nonhospitalized stroke patients was obtained by physician
questionnaire. This information was reviewed by a CHS
neurologist at each ﬁeld center, and any inconsistencies
were reviewed with the participant’s physician. Potential
stroke cases were adjudicated by a committee of neurol-
ogists, neuroradiologists, and internists using information
from interviews, medical records, and available cerebral
imaging studies. Adjudication decisions were usually unan-
imous in terms of presence of stroke, stroke subtype, and
stroke as a cause of death.
Statistical Analysis
Independent-samples t tests for continuous variables and v2
tests for categorical variables were used to determine which
components of the CHS-SCORE and which HRV parameters
differed between participants with and without incident
stroke. Analyses evaluated the CHS-SCORE and HRV in
relation to incident stroke primarily as continuous variables,
and secondarily as categorical variables. Cox proportional
hazards models were ﬁtted to calculate the unadjusted and
adjusted hazard ratios (HRs) and 95% CIs for the CHS-
DOI: 10.1161/JAHA.116.004305 Journal of the American Heart Association 3






















SCORE and HRV measures in relation to incident stroke. The
additional contribution of HRV was assessed by entering
the CHS-SCORE as a continuous variable at the ﬁrst step of
the stepwise forward conditional multivariate Cox regression
analysis, including all nonoverlapping 24-hour HRV and
ectopy measures, signiﬁcantly different between participants
with and without incident stroke at the second step, and
allowing the software to pick the best model (using P<0.05
for selection based on the Wald statistic). When both time
domain and frequency domain parameters reﬂecting the
same underlying autonomic rhythms (eg, total power and
SDNN, which each reﬂect total HRV) were both different
between groups, we chose the frequency domain HRV
parameter as a candidate variable in the stepwise model.
The c-statistic, a measure of the accuracy of discrimination
that can be thought of as an extension of the binary
receiver-operating characteristic curve to multivariable sur-
vival analysis, was calculated and compared across succes-
sive models.20 Model calibration was assessed using the
Hosmer-Lemeshow goodness-of-ﬁt statistic. Statistical Pack-
age for Social Sciences, SPSS v.23 (SPSS, Inc, Chicago, IL)
was used for all analyses. MedCalc software v.17.1 (www.
MedCalc.org) was used to calculate the P values for the
difference in c-statistics. A 2-sided P<0.05 was considered
to be statistically signiﬁcant.
Results
There were 884 CHS participants (338 men, 546 women; age
75.34.6 years) included in the analysis. Among the 68
participants with incident stroke, time to stroke was
3.52.0 years (range 0.03–7.7 years).
Table 2 compares the components of the CHS stroke risk
model in participants with valid Holter recordings who did and
did not suffer a stroke after the 1994–1995 visit. Notably,
participants with incident strokes tended to be slightly older,
and have signiﬁcantly higher systolic blood pressure, but
many of the speciﬁc components of the risk score were not
different. However, as can be seen in the table, the CHS-
SCORE itself was signiﬁcantly higher in participants with
incident stroke versus those without (19.18.2 versus
16.16.9, P=0.004).
CHS-SCORE and Outcome
Consistent with the ﬁndings in the original CHS cohort at
baseline, the CHS-SCORE, when calculated at the 1994–1995
visit in the Holter subcohort, was signiﬁcantly associated with
incident stroke (HR=1.06 per unit increment; 95% CI 1.03–
1.10, P<0.001). The c-statistic was 0.61. There was no
evidence of miscalibration (Hosmer–Lemeshow goodness-
of-ﬁt, P=0.628).
Table 2. Comparison of Components of the CHS Stroke Risk Score Between Participants With Valid 1994–1995 Holter
Recordings With and Without an Incident Stroke on Follow-Up
No Stroke (N=816) Incident Stroke (N=68) P Value
Systolic blood pressure, mm Hg 13320 13920 0.013
15-foot walk time, s 5.42.1 5.81.9 NS
Left ventricular hypertrophy by ECG (Y/N) 41 (5.0%) 4 (5.9%) NS
Creatinine, mg/dL* 1.040.28 1.050.27 NS
ADA diabetic status* 0.084
Normal, % (<110 mg/dL) 593 (72.7%) 43 (63.2%)
IFG, % (110–126 mg/dL) 90 (11.0%) 9 (13.2%)
Diabetes mellitus, % (>126 mg/dL or taking meds) 133 (16.3%) 16 (23.5%)
Age at year 7, y 75.24.5 76.55.4 0.058
Sex, % NS
Female 499 (61.2%) 47 (69.1%)
Male 317 (38.8%) 21 (30.9%)
Atrial fibrillation by ECG, % 0 0 NS
History of heart disease at 1994–1995 visit (y 7) (Y/N) 159 (19.5%) 16 (23.5%) NS
CHS stroke risk score 16.16.9 19.18.2 0.004
ADA, American Diabetes Association; CHS, Cardiovascular Health Study; IFG, Impaired Fasting Glucose; NS, Not Signiﬁcant.
Clinical factors measured at the 1994–1995 examination.
*Lab values measured at the 1992–1993 examination.
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Association of HRV With Incident Stroke
Table 3 compares 24-hour HRV measures between partici-
pants with and without incident stroke. Deﬁnitions for all HRV
parameters are provided in the legend for Table 3. As seen in
the table, although 24-hour heart rate was not different
between participants with and without incident stroke, the
coefﬁcient of variance, SDNN Index, and natural log-
transformed values for total power, ultra-low-frequency
power, and very-low-frequency power were signiﬁcantly lower,
and power law slope (SLOPE) was signiﬁcantly more negative
in participants with incident stroke. Also, in an exploratory
analysis, there were no signiﬁcant differences in HRV
parameters between participants with ischemic versus other
(hemorrhagic or unknown) subtypes of stroke (P>0.21), but
the sample size was too small (N=55 ischemic strokes, N=13
other or unknown) to consider this ﬁnding deﬁnitive.
HRV Parameters Independently Associated With
Risk of Stroke
After inclusion of the continuous CHS-SCORE, the HRV
parameters, coefﬁcient of variance (CV%) (HR=0.92, 95% CI
Table 3. Comparison of 24-Hour HRV Measures and Ectopy Counts Between Participants With and Without Incident Stroke on
Follow-Up
Time Domain HRV Variables No Stroke (N=816) Incident Stroke (N=68) P Value
Heart rate, beats per min 73.59.7 73.19.5 NS
SDNN, ms 115.934.5 106.936.6 0.054
SDANN, ms 105.233 97.836.9 NS
CV, % 13.93.6 12.83.9 0.019
SDNN index, ms 41.915.4 38.113.2 0.025
RMSSD, ms 26.115.9 2412.5 NS
Frequency domain HRV variables
ln (total power) 4.10.28 4.00.29 0.035
ln (ultra-low-frequency power) 4.00.29 3.90.30 0.048
ln (very-low-frequency power) 2.90.30 2.80.33 0.033
Normalized low-frequency power (5-min averages) 59.211 57.210.3 NS
Normalized high-frequency power (5-min averages) 26.69.6 27.89.2 NS
ln (low-frequency power) (5-min averages) 2.50.39 2.40.41 0.052
ln (high-frequency power) (5-min averages) 2.10.46 2.00.42 NS
Nonlinear HRV variables
Short-term fractal scaling exponent (DFA1) 1.130.21 1.100.20 NS
Intermediate-term fractal scaling exponent (DFA2) 1.230.15 1.240.13 NS
SD1/SD2 0.280.11 0.290.09 NS
Power law slope (SLOPE) 1.360.15 1.420.14 0.003
Ectopy counts N=816 N=68
ln (VPC+1) 3.72.3 4.02.3 NS
ln (APC+1) 4.51.6 4.51.4 NS
Time domain heart rate variability (HRV) variables: SDNN (ms)=SD of all normal-to-normal (N-N) intervals; SDANN (ms)=SD of the averages of N-N intervals for all 5-min segments; CV (%)
=average coefﬁcient of variance of N-Ns for 5-min segments for 24 ; SDNN Index (ms)=mean of 5-min SDs of all N-N intervals for 24 h; RMSSD (ms)=square root of the mean of the
squared differences between successive N-N intervals for 24 h. Frequency domain HRV: Total Power=all of the variance in HRV; Ultra-low-frequency power=all variance in 24-h HRV at
frequencies of every 5 min to every 24 h, thus reﬂecting primarily circadian HRV; Very-low-frequency power=variance in HRV at underlying frequencies of every 25 s to every 5 min
calculated for every 15-min segment and averaged; Normalized low-frequency power=the average proportion of HRV in each 5 min that is explained by oscillations at underlying
frequencies of 0.04 to 0.15 Hz (the low-frequency band) divided by the total HRV in that 5-min period; Normalized high-frequency power=the average amount of HRV in each 5 minutes
that is explained by oscillations at underlying frequencies 0.15 to 0.4 Hz (high-frequency or respiratory frequency band) divided by total HRV in that 5-min period; ln (LF)=natural log of low-
frequency power. LF captures the variance in HRV at underlying frequencies of 0.04 to 0.15 Hz; ln (HF)=natural log of high-frequency power. High frequency captures the variance in HRV
at underlying frequencies of 0.18 to 0.4 Hz. Nonlinear HRV variables: DFA1=short-term fractal scaling exponent calculated over 3 to 11 beats and averaged over 1000 beats for 24 h;
DFA2=longer-term fractal exponent calculated over 12 to 20 beats and averaged over 1000 beats for 24 h; SD12=Poincare ratio. The Poincare plot is a scatterplot of each N-N interval vs
the next. SD1 is the short axis of an ellipse ﬁtted to the Poincare plot. SD2 is the long axis of the same ellipse. SD12 (SD1/SD2) is the ratio of the short and long axes of ellipse and
reﬂects the organization of the N-N interval time series. SD12 was calculated for each 1000 beats and averaged; Power law slope=slope of a line ﬁtted to a plot of log spectral power vs log
of underlying frequency between 102 and 104 Hz over 24 h. Ectopy counts: ln (VPC+1)=natural log transformation of the number of premature ventricular contractions +1; ln (APC+1)
=natural log transformation of the number of premature atrial contractions +1. NS indicates Not Signiﬁcant.
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0.86–0.99, P=0.031) and SLOPE (HR=0.17, 95% CI 0.03–
0.87, P=0.033) were retained in the multivariable Cox model.
The c-statistic for the model with the CHS SCORE and both
HRV parameters added was 0.63. The change in the c-statistic
compared with the model with the CHS-SCORE alone was not
statistically signiﬁcant (P=0.47). However, the association
between the CHS-SCORE and incident stroke (HR=1.05 per
unit increment, 95% CI, 1.01–1.08, P=0.005) was not
meaningfully attenuated by the addition of HRV parameters.
CV% and SLOPE capture completely different aspects of
HRV. We therefore performed a detailed secondary analysis to
further explore the relationship between decreased CV%,
more negative SLOPE, and incident stroke. Clinical cut points
for CV% and SLOPE have not been established. We therefore
dichotomized each at the cut point that maximally separated
participants with and without incident stroke after adjustment
for the continuous CHS-SCORE. For CV%, optimal risk
separation occurred at a cut point of CV% ≤12.8 (LOWCV%).
Among the 884 study participants, 379 had LOWCV% and 505
had CV% >12.8 (HIGHCV%). Among the participants with
LOWCV%, N=43 (11.3%) had incident stroke and among the
participants with HIGHCV%, N=25 (5%) had incident stroke.
When categorized CV% was added to the continuous CHS-
SCORE, being in the LOWCV% group was associated with an
HR=2.24 (95% CI=1.37–3.68, P=0.001) for incident stroke.
The optimal risk separation for SLOPE occurred at
SLOPE=1.4. Among the 884 study participants, 350 had
SLOPE <1.4 (LOWSLOPE) and 534 had SLOPE ≥1.4
(HIGHSLOPE). Among the participants with LOWSLOPE, N=39
(11.1%) had an incident stroke and among the participants
with HIGHSLOPE, N=29 (5.4%) had an incident stroke. After
adjustment for the CHS-SCORE, being in the LOWSLOPE
group was associated with HR=1.82 (95% CI=1.10–3.00,
P=0.018) for incident stroke.
To explore whether having both types of abnormal HRV
would be associated with an additional risk of incident stroke,
we created combined categories of high- and low-risk groups
for CV% and SLOPE. When combined categories of HRV were
added to the continuous CHS-SCORE in the Cox model, being
in the higher risk category for both HRV measures (LOWCV%
and LOWSLOPE) was associated with a HR=3.5 (95% CI=1.8–
6.8, P<0.001) for incident stroke compared with being in the
lowest risk group for both parameters. Figure shows the
incident stroke survival curves by combined categories of HRV
after adjustment for the continuous CHS-SCORE. The corre-
sponding risk estimate for each category of combined HRV
parameters compared with the reference category of HIGHCV
%-HIGHSLOPE is shown in the legend for Figure. The
c-statistic of the model with combined categories of HRV
parameters adjusted for the CHS-SCORE was 0.68 compared
with the c-statistic of 0.61 of the model with CHS-SCORE
alone (P value for the difference in c-statistic=0.02). There
was no evidence of miscalibration (Hosmer–Lemeshow good-
ness-of-ﬁt P=0.723).
Discussion
Results of our study show that information from 24-hour
Holter monitoring is signiﬁcantly associated with incident
stroke among community-dwelling older adults in normal
sinus rhythm, even after calculation of their stroke risk using a
validated clinical score, and could potentially improve risk
stratiﬁcation for incident stroke in this population. The CHS-
SCORE includes commonly assessed risk factors, namely,
age, sex, systolic blood pressure, 15-foot walk time, diabetic
status, left ventricular hypertrophy on ECG, history of heart
disease, and AF by ECG, the last of which was an exclusion
criterion in the current study. Although having these risk
factors could result in decreased HRV, abnormal HRV
parameters proved independent of this composite index in
this cohort late in life.
A strength of this study is that participants were well
characterized and events were carefully adjudicated. Further-
more, all Holter recordings were analyzed to research
standards. Findings are consistent with pre-existing auto-
nomic dysfunction occurring, in many cases, years before the
stroke itself.
Figure. Survival curves for incident stroke based on combined
categories of higher and lower coefﬁcient of variance (CV%) and
power law slope (SLOPE) after adjustment for continuous
CHS-SCORE. Reference category is HIGHCV%-HIGHSLOPE.
HIGHCV%-LOWSLOPE: HR=1.3 (95% CI=0.6–2.8, P=0.59);
LOWCV%-HIGHSLOPE: HR=1.6 (95% CI=0.8–3.4, P=0.19);
LOWCV%-LOWSLOPE: HR=3.5 (95% CI=1.8–6.8, P<0.001) where
LOWCV%=CV% ≤12.8%, HIGHCV%=CV% >12.8%, LOWSLOPE=
SLOPE <1.4, HIGHSLOPE=SLOPE ≥1.4. CHS-SCORE indicates
Cardiovascular Health Study stroke risk score; HR, hazard ratio.
DOI: 10.1161/JAHA.116.004305 Journal of the American Heart Association 6






















The parameter CV% was 1 of 2 HRV measures that were
signiﬁcantly associated with incident stroke when added to
the CHS-SCORE. CV% is deﬁned as the mean over 24 hours of
the variance of the N-N interval time series for each 5-minute
period divided by the mean N-N interval for that 5-minute
period, expressed as a percentage, essentially the heart rate–
adjusted localized HRV. Our results suggest that decreased
CV% may capture a diminished global autonomic functioning
that is related to stroke risk independent of clinical measures
subsumed by the CHS-SCORE. Moreover, when CV% was
dichotomized into HIGHCV% (>12.8%) and LOWCV% (≤12.8%)
based on maximal discrimination of stroke risk in the current
cohort—no cut point for CV% has been published previously
—participants in the LOWCV% group were 2.2 times more
likely to suffer a subsequent stroke than those in the HIGHCV
% group, independent of their CHS-SCORE. Because this cut
point is based on the present data, it will need to be validated
in other populations.
The SLOPEwas the second HRVmeasure that demonstrated
a signiﬁcant association with future stroke, independent of the
CHS-SCORE. A negative number, the SLOPE reﬂects the
distribution of the spectral characteristics of N-N interval
oscillations. It is the slope of a line ﬁtted to a plot of log spectral
power versus log of underlying frequency between 102 and
104 Hz over 24 hours. Consistent with our results, it has
previously been reported that decreased SLOPE is associated
with increased risk of cerebrovascular death in the elderly.21 It
is possible that altered cardiovascular neural regulation,
expressed by a lower value of SLOPE, is a sign of subclinical
vascular disease predisposing to stroke as well as cerebrovas-
cular death. Lower values for SLOPE may also reﬂect impair-
ment in the intrinsic physiological regulatory and adaptive
systems associated with aging, leading to cardiovascular and
cerebrovascular events as well as death. When slope was
dichotomized as <1.40 (LOWSLOPE) and ≥1.40 (HIGH-
SLOPE) to optimize discrimination in the current sample,
participants in the lower category had a 1.8-fold higher risk of
incident stroke than those in the higher category. This cut point
will require validation in separate cohorts.
There was an additive effect of CV% and SLOPE, wherein
participants with LOWCV% and LOWSLOPE had the highest
overall risk of stroke. Furthermore, in this secondary analysis,
the combined categories of HRV signiﬁcantly improved risk
prediction when added to the CHS score. Once again,
because the cut points selected for categorization of the
HRV parameters were derived from our sample, future studies
will need to test discriminative performance of this catego-
rization in different populations.
We are aware of only 1 other study, by Binici et al,12
examining HRV and risk of incident stroke. This study was a
population-based cohort, the Copenhagen Holter Study, with
678 participants who had 48-hour ambulatory ECG
monitoring. Although SDNN was the HRV parameter of
interest, surprisingly, SDNN as a predictor of incident stroke
was measured from 2:00 to 2:15 AM only and even so, it could
only be evaluated in 653 participants. The investigators found
a signiﬁcant association between 15 minutes of nighttime
HRV and stroke, and concluded that nocturnal HRV was a
marker for development of stroke in healthy adults. In
contrast, our study had multiple measures of HRV calculated
from longer durations. Although, in theory, we could calculate
SDNN between 2:00 and 2:15 AM for each participant, it is
unlikely that this would improve risk stratiﬁcation for incident
stroke.
What is also notable is the difference in the HRV risk
factors associated with incident stroke compared with the
HRV risk factors previously found to be associated with risk of
cardiovascular mortality in the CHS.1 For example, decreased
values for the short-term fractal scaling exponent (DFA1 [a
measure of the organization, ie, randomness versus pre-
dictability of the heart rate time series]) has strongly
predicted cardiovascular mortality in the CHS and in other
populations,1 but DFA1 was not signiﬁcantly different
between participants with and without incident stroke. Also,
greater atrial and ventricular ectopy counts were risk markers
for worse cardiovascular outcomes in the CHS,22 but no
signiﬁcant difference was found in the atrial or ventricular
ectopy counts between those who did and did not suffer a
stroke. Finally, 24-hour averaged heart rate, another risk
factor for adverse cardiovascular outcomes, was not different
among the participants who did and did not suffer a stroke.
Limitations
A limitation of the current study is the modest sample size.
Also, while the clinical stroke risk model can be applied to all
older adults in whom the components have beenmeasured, the
HRV-adjusted model can only be applied to people in normal
sinus rhythm and with fewer than 20% ectopic beats. Record-
ings from participants with AF/ﬂutter, wandering atrial pace-
maker, or a paced rhythm were excluded from analysis a priori.
This may account for the lack of association between atrial
premature contractions counts and stroke, although an
association between atrial premature contractions and AF,23
and AF and incident stroke has been previously been demon-
strated in the CHS.24 Furthermore, we limited our analysis to
participants with recordings adequate for 24-hour time domain,
frequency domain, and nonlinear HRV analysis. The healthier
resulting subcohort may account for the difference in the c-
statistic for the CHS-SCORE in the present study (0.61) as
compared with that obtained in the original cohort of 5888
participants in whom the CHS-SCORE was developed and
validated (0.73). Given the modest discriminatory capacity of
the CHS-SCORE in our subcohort, further research is needed to
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determine to what extent HRV measures might improve risk
prediction over optimally performing clinical scores. Also, we
have evaluated the incremental predictive value of HRV
parameters against the CHS score, but not against the
individual components of the score itself because of the low
number of events. Finally, there were not enough events to
determine whether HRV would be different in participants with
ischemic versus nonischemic stroke, but when the CHS stroke
risk score was developed, the model predicted both types of
stroke equally well.14
Future Directions
Our results support the associations of CV% and SLOPE with
incident stroke independent of the CHS-SCORE. These
ﬁndings suggest that HRV might be useful for further risk
stratiﬁcation of older adults in relation to incident stroke,
which could allow enhanced preventive approaches in this
population. The present ﬁndings require separate investiga-
tion in larger cohorts to better determine the clinical value of
HRV from 24-hour Holters, including for conﬁrmation of the
primacy of the 2 HRV measures identiﬁed here, and for
validation of the cut points selected. Moreover, future studies
need to test the added value of HRV measures for risk
stratiﬁcation for incident stroke against other validated
clinical risk scores, as well as the potential for HRV derived
from shorter recordings to add to risk stratiﬁcation. Pending
conﬁrmation, additional studies could also examine whether
the efﬁcacy of interventions that might decrease risk is
reﬂected in improvements in HRV.
Conclusions
Among community-dwelling older adults in the CHS, we have
shown, for the ﬁrst time, that HRV parameters are signiﬁ-
cantly associated with risk of incident stroke, and that a
composite measure involving optimized cut points of 2 such
parameters, CV% and SLOPE, improves prediction of incident
stroke over a validated clinical risk score during 8 years of
follow-up. These ﬁndings will require additional investigation
in larger samples and in different populations.
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